Latest news
Tergus Pharma Announces Michael Kane as Chief Executive Officer
Durham, NC – Tergus Pharma, a commercial scale Contract Development and Manufacturing Organization (CDMO) of semi-solid and liquid dosage forms,
Tergus Pharma Makes Key Executive Hires
DURHAM, N.C. September 8, 2021 — Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO) with proven topical
Tergus Pharma Officially Opens New Headquarters
Tergus Pharma to Participate in ECRM Contract Services Program for OTC Health and Supplements
DURHAM, N.C. February 9, 2021 – Tergus Pharma announced today that the company will be participating in ECRM’s virtual trade
Tergus Pharma and Phenom Pharmaceuticals Collaborate to Develop Novel Delivery System for SARS-CoV-2 Anti-Binding Agent
DURHAM, N.C. October 28, 2020 – Tergus Pharma and Phenom Pharmaceuticals announced today that they have entered into an agreement
Tergus Pharma Ramping up to Open Industry’s Largest Topical Contract Development and Manufacturing Organization (CDMO)
DURHAM, N.C., OCTOBER 15, 2020 — Significant progress continues to be made on the construction of Tergus Pharma’s new, state-of-the-art research
Tergus Pharma Makes Key Executive Leadership Hires
DURHAM, N.C. September 30, 2020 — Tergus Pharma, the leading topical contract development and manufacturing organization (CDMO) with proven expertise
Tergus Pharma Receives 2020 Customer Value Leadership Award
With its strong overall performance, Tergus Pharma earns Frost & Sullivan’s 2020 North America Customer Value Leadership Award in the